144 related articles for article (PubMed ID: 26897854)
1. [The Laboratory Medicine of Lipid Mediators].
Yatomi Y
Rinsho Byori; 2015 Oct; 63(10):1183-6. PubMed ID: 26897854
[TBL] [Abstract][Full Text] [Related]
2. Lysophospholipids in laboratory medicine.
Yatomi Y; Kurano M; Ikeda H; Igarashi K; Kano K; Aoki J
Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(10):373-389. PubMed ID: 30541965
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects.
Ohkawa R; Kurano M; Mishima Y; Nojiri T; Tokuhara Y; Kishimoto T; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Yokota H; Igarashi K; Ikeda H; Tozuka M; Yatomi Y
Clin Biochem; 2015 Jul; 48(10-11):690-7. PubMed ID: 25863111
[TBL] [Abstract][Full Text] [Related]
4. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
Yatomi Y
Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
[TBL] [Abstract][Full Text] [Related]
6. [Laboratory-Based Clinical Research I am Aiming for].
Yatomi Y
Rinsho Byori; 2014 Nov; 62(11):1052-5. PubMed ID: 27509720
[TBL] [Abstract][Full Text] [Related]
7. Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.
Kurano M; Kano K; Dohi T; Matsumoto H; Igarashi K; Nishikawa M; Ohkawa R; Ikeda H; Miyauchi K; Daida H; Aoki J; Yatomi Y
J Lipid Res; 2017 Feb; 58(2):433-442. PubMed ID: 28007846
[TBL] [Abstract][Full Text] [Related]
8. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
[TBL] [Abstract][Full Text] [Related]
10. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
[TBL] [Abstract][Full Text] [Related]
11. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin in liver fibrosis.
Ikeda H; Yatomi Y
Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
[TBL] [Abstract][Full Text] [Related]
13. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
14. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
[TBL] [Abstract][Full Text] [Related]
15. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis.
Tokumura A; Carbone LD; Yoshioka Y; Morishige J; Kikuchi M; Postlethwaite A; Watsky MA
Int J Med Sci; 2009 Jun; 6(4):168-76. PubMed ID: 19521548
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of autotaxin, a lysophosphatidic acid-producing enzyme, enhances cardia bifida induced by hypo-sphingosine-1-phosphate signaling in zebrafish embryo.
Nakanaga K; Hama K; Kano K; Sato T; Yukiura H; Inoue A; Saigusa D; Tokuyama H; Tomioka Y; Nishina H; Kawahara A; Aoki J
J Biochem; 2014 Apr; 155(4):235-41. PubMed ID: 24451492
[TBL] [Abstract][Full Text] [Related]
18. Decrease in circulating autotaxin by oral administration of prednisolone.
Sumida H; Nakamura K; Yanagida K; Ohkawa R; Asano Y; Kadono T; Tamaki K; Igarashi K; Aoki J; Sato S; Ishii S; Shimizu T; Yatomi Y
Clin Chim Acta; 2013 Jan; 415():74-80. PubMed ID: 23063960
[TBL] [Abstract][Full Text] [Related]
19. Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay.
Ohkawa R; Kurano M; Sakai N; Kishimoto T; Nojiri T; Igarashi K; Hosogaya S; Ozaki Y; Dohi T; Miyauchi K; Daida H; Aoki J; Okubo S; Ikeda H; Tozuka M; Yatomi Y
Sci Rep; 2018 Mar; 8(1):4725. PubMed ID: 29549312
[TBL] [Abstract][Full Text] [Related]
20. Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice: role of blood cell-associated lysophospholipase D activity of autotaxin.
Shimizu Y; Morikawa Y; Okudaira S; Kimoto S; Tanaka T; Aoki J; Tokumura A
Am J Pathol; 2014 May; 184(5):1593-603. PubMed ID: 24641902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
